{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:09:22Z","timestamp":1772136562249,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3384,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1038\/sj.ki.5001732","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T05:28:03Z","timestamp":1154496483000},"page":"1170-1176","source":"Crossref","is-referenced-by-count":11,"title":["Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis"],"prefix":"10.1016","volume":"70","author":[{"given":"R.","family":"Minutolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Balletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Tirino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zamboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fuiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Marotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"De Nicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5001732_bb0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(05)17789-7","article-title":"Chronic kidney disease: the global challenge","volume":"365","author":"El Nahas","year":"2005","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5001732_bb0015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0140-6736(99)90122-8","article-title":"Renoprotective therapy: titration against urinary protein excretion","volume":"354","author":"De Jong","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5001732_bb0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1172\/JCI27699","article-title":"Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes","volume":"116","author":"Remuzzi","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001732_bb0025","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1046\/j.1523-1755.1998.00874.x","article-title":"Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies","volume":"53","author":"Ruggenenti","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0030","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","article-title":"Proteinuria and the risk of developing end-stage renal disease","volume":"63","author":"Iseki","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency","volume":"354","author":"Hou","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5001732_bb0040","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1681\/ASN.V12122832","article-title":"ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results","volume":"12","author":"Ruggenenti","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001732_bb0045","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0272-6386(99)70416-6","article-title":"Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy","volume":"33","author":"Russo","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001732_bb0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/ajkd.2001.25176","article-title":"Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy","volume":"38","author":"Russo","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001732_bb0055","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1523-1755.2005.00145.x","article-title":"Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic kidney disease: pathophysiology and indications","volume":"67","author":"Wolf","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","article-title":"Combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial","volume":"361","author":"Nakao","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5001732_bb0065","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.2003.00015.x","article-title":"Maximal suppression of renin\u2013angiotensin system in non-proliferative glomerulonephritis","volume":"63","author":"Iodice","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0070","first-page":"397","article-title":"Management of hypertension in chronic kidney disease: the Italian Multicentric Study","volume":"18","author":"De Nicola","year":"2005","journal-title":"J Nephrol"},{"key":"10.1038\/sj.ki.5001732_bb0075","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.ki.5000085","article-title":"Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention","volume":"69","author":"De Nicola","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0080","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001732_bb0085","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","article-title":"Effect of inhibitors of the renin\u2013angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis","volume":"366","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5001732_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/hy0102.100536","article-title":"Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats","volume":"39","author":"Nishiyama","year":"2002","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5001732_bb0095","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/01.ASN.0000026610.48842.CB","article-title":"Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition","volume":"13","author":"Nishiyama","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001732_bb0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.HYP.32.3.387","article-title":"Pathways for angiotensin II generation in intact human tissue. Evidence from comparative pharmacological interruption of the renin system","volume":"32","author":"Hollemberg","year":"1998","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5001732_bb0105","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1046\/j.1523-1755.1998.00159.x","article-title":"Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis","volume":"54","author":"Takashi","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0110","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1097\/01.ASN.0000071512.93927.4E","article-title":"Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease","volume":"14","author":"Huang","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001732_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/ajkd.2002.29909","article-title":"Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels","volume":"39","author":"Komine","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001732_bb0120","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1046\/j.1523-1755.2003.00832.x","article-title":"Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropaties","volume":"63","author":"Campbell","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.ajkd.2003.10.032","article-title":"Low-dose dual blockade of the renin\u2013angiotensin system in patients with primary glomerulonephritis","volume":"43","author":"Rutkowski","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001732_bb0130","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1523-1755.2002.00536.x","article-title":"Dual renin\u2013angiotensin system blockade at optimal doses for proteinuria","volume":"62","author":"Laverman","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00004872-200201000-00018","article-title":"Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade","volume":"20","author":"Ferrari","year":"2002","journal-title":"J Hypertension"},{"key":"10.1038\/sj.ki.5001732_bb0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/ajkd.2003.50039","article-title":"Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropaties","volume":"41","author":"Morales","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001732_bb0145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0272-6386(12)80483-5","article-title":"Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition","volume":"17","author":"Praga","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001732_bb0150","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.ajkd.2004.08.041","article-title":"Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary","volume":"45","author":"Weir","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001732_bb0155","first-page":"57","article-title":"Predicting outcome in the idiopathic glomerulopathies","volume":"11","author":"Cattran","year":"1998","journal-title":"J Nephrol"},{"key":"10.1038\/sj.ki.5001732_bb0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/ajkd.2003.50015","article-title":"Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis","volume":"41","author":"Dumoulin","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001732_bb0165","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ndt\/gfh633","article-title":"Histological grading of IgA nephropathy predicting renal outcome: revisiting HS Lee's glomerular grading system","volume":"20","author":"Lee","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001732_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1399-0012.1998.tb00990.x","article-title":"Antiproteinuric efficacy of lisinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage","volume":"12","author":"Lufft","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1038\/sj.ki.5001732_bb0175","first-page":"F457","article-title":"ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy","volume":"276","author":"Remuzzi","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1038\/sj.ki.5001732_bb0180","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1523-1755.1999.055003877.x","article-title":"Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis","volume":"55","author":"Nakamura","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0185","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1442-200x.2004.01955.x","article-title":"Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy","volume":"46","author":"Tanaka","year":"2004","journal-title":"Pediatr Int"},{"key":"10.1038\/sj.ki.5001732_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000083224","article-title":"Tissue-specific expression of renin\u2013angiotensin system components in IgA nephropathy","volume":"25","author":"Ogawa-Miyake","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1038\/sj.ki.5001732_bb0195","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ki.1991.273","article-title":"Angiotensin receptor-mediated proliferation of cultured human fetal mesangial cells","volume":"40","author":"Ray","year":"1991","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0200","first-page":"95","article-title":"Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells","volume":"140","author":"Wolf","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.ki.5001732_bb0205","first-page":"F158","article-title":"Role of mesangial cell in glomerular response to volume and angiotensin II","volume":"264","author":"Blantz","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1038\/sj.ki.5001732_bb0210","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.HYP.37.4.1171","article-title":"Activation of NF-\u03baB in tubular epithelial cells of rats with intense proteinuria. Role of angiotensin II and endothelin-1","volume":"37","author":"G\u00f3mez-Garre","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5001732_bb0215","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/01.HYP.33.2.732","article-title":"Angiotensin converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria","volume":"33","author":"Largo","year":"1999","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5001732_bb0220","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/ajkd.2002.31399","article-title":"Regression of IgA nephropathy. A repeat biopsy study","volume":"39","author":"Hotta","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001732_bb0225","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1097\/01.ASN.0000146121.72699.86","article-title":"Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature","volume":"15","author":"Adamczak","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001732_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/ndt\/gfi291","article-title":"Progression versus regression of chronic kidney disease","volume":"21","author":"Fogo","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001732_bb0235","series-title":"Nutrition and the Kidney","first-page":"61","article-title":"Assessment of nutritional status in renal disease","author":"Dwyer","year":"1993"},{"key":"10.1038\/sj.ki.5001732_bb0240","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.ki.5001732_bb0245","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJM199809243391306","article-title":"Glomerulonephritis","volume":"339","author":"Hricik","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5001732_bb0250","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1046\/j.1523-1755.2001.0590031052.x","article-title":"Renal hemodynamic response to maximal vasodilating stimulus in healthy elderly subjects","volume":"59","author":"Fuiano","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0255","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001732_bb0260","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1699-0463.1998.tb00254.x","article-title":"Morphological studies of baseline needle biopsies from living donor kidneys: light microscopic, immunohistochemical and ultrastructural findings","volume":"106","author":"Sund","year":"1998","journal-title":"APMIS"},{"key":"10.1038\/sj.ki.5001732_bb0265","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1699-0463.1989.tb00464.x","article-title":"Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic","volume":"97","author":"Svanholm","year":"1989","journal-title":"APMIS"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815520796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815520796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T03:45:24Z","timestamp":1736480724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815520796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0085253815520796"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5001732","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1040141.489060","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}